Biomarker Technologies Market Report 2019 | Market Set to Reach $58.5 Billion by 2026, Rising at a CAGR of 13.2%

Ads

You May Also Like

Relievant Announces Reimbursement Codes and APC Assignment for The Intracept® Procedure

MINNEAPOLIS, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company ...

AZ completes US Aralez agreement for Toprol-XL

31 October 2016 13:45 ASTRAZENECA COMPLETES AGREEMENT WITH ARALEZ FOR BETA-BLOCKER MEDICINE TOPROL-XL IN ...